Remove Contract Manufacturing Remove Marketing Remove Pharma Production Remove Sales
article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

article thumbnail

Benefits of Third Party Manufacturing of Pharmaceuticals

Fossil Remedies

If you partner with a company that offers the best products to your channel partners and customers, then you build a good reputation in the market. It is a win-win situation for you and the pharma company. It is a favorable business model for both, you and the manufacturing partner. It is a great benefit for you.